Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BPTS NYSE:CCV NASDAQ:FWAA NASDAQ:HCAQ On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBPTSBiophytis$13.37$8.05▼$168.80$2.89M1.057,291 shs18,500 shsCCVChurchill Capital Corp V$10.40$10.39$9.90▼$11.00$283.58MN/A167,770 shs23,136 shsFWAAFifth Wall Acquisition Corp. I$1.46-0.7%$12.40$9.77▼$12.92$51.90MN/A368,485 shs817,609 shsHCAQHealthCor Catalio Acquisition$1.23-3.9%$8.72$9.48▼$11.00$26.22MN/A114,974 shs1.53 million shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBPTSBiophytis0.00%0.00%0.00%0.00%0.00%CCVChurchill Capital Corp V0.00%0.00%0.00%0.00%0.00%FWAAFifth Wall Acquisition Corp. I+4.26%+1.38%-6.96%+37.38%-15.52%HCAQHealthCor Catalio Acquisition-1.54%-37.56%-11.72%+14.29%+25.49%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBPTSBiophytis$13.37$8.05▼$168.80$2.89M1.057,291 shs18,500 shsCCVChurchill Capital Corp V$10.40$10.39$9.90▼$11.00$283.58MN/A167,770 shs23,136 shsFWAAFifth Wall Acquisition Corp. I$1.46-0.7%$12.40$9.77▼$12.92$51.90MN/A368,485 shs817,609 shsHCAQHealthCor Catalio Acquisition$1.23-3.9%$8.72$9.48▼$11.00$26.22MN/A114,974 shs1.53 million shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBPTSBiophytis0.00%0.00%0.00%0.00%0.00%CCVChurchill Capital Corp V0.00%0.00%0.00%0.00%0.00%FWAAFifth Wall Acquisition Corp. I+4.26%+1.38%-6.96%+37.38%-15.52%HCAQHealthCor Catalio Acquisition-1.54%-37.56%-11.72%+14.29%+25.49%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBPTSBiophytis 0.00N/AN/AN/ACCVChurchill Capital Corp V 0.00N/AN/AN/AFWAAFifth Wall Acquisition Corp. I 0.00N/AN/AN/AHCAQHealthCor Catalio Acquisition 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBPTSBiophytisN/AN/AN/AN/A($17.29) per shareN/ACCVChurchill Capital Corp VN/AN/A$1.94 per share5.36($1.68) per shareN/AFWAAFifth Wall Acquisition Corp. IN/AN/AN/AN/A$0.14 per shareN/AHCAQHealthCor Catalio AcquisitionN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBPTSBiophytis-$18.43MN/A0.00N/AN/AN/AN/AN/AN/ACCVChurchill Capital Corp V$24.09MN/A0.00∞N/AN/A-30.29%2.28%N/AFWAAFifth Wall Acquisition Corp. IN/AN/A0.00∞N/AN/AN/AN/AN/AHCAQHealthCor Catalio AcquisitionN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBPTSBiophytisN/AN/AN/AN/AN/ACCVChurchill Capital Corp VN/AN/AN/AN/AN/AFWAAFifth Wall Acquisition Corp. IN/AN/AN/AN/AN/AHCAQHealthCor Catalio AcquisitionN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBPTSBiophytisN/A0.720.72CCVChurchill Capital Corp VN/A0.070.07FWAAFifth Wall Acquisition Corp. IN/A0.780.78HCAQHealthCor Catalio AcquisitionN/A0.480.48Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBPTSBiophytis0.05%CCVChurchill Capital Corp V52.51%FWAAFifth Wall Acquisition Corp. I87.66%HCAQHealthCor Catalio Acquisition84.18%Insider OwnershipCompanyInsider OwnershipBPTSBiophytis3.70%CCVChurchill Capital Corp V20.00%FWAAFifth Wall Acquisition Corp. IN/AHCAQHealthCor Catalio AcquisitionN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBPTSBiophytis22351,000338,000Not OptionableCCVChurchill Capital Corp V227.28 million21.82 millionNot OptionableFWAAFifth Wall Acquisition Corp. I235.55 millionN/ANot OptionableHCAQHealthCor Catalio Acquisition221.31 millionN/ANot OptionableHCAQ, BPTS, FWAA, and CCV HeadlinesRecent News About These CompaniesHealthCor Catalio Acquisition Dividend Per Share (TTM)December 26, 2021 | ycharts.comYHealthCor Catalio Acquisition Alpha (5Y)December 26, 2021 | ycharts.comYHyperfine Closes Business Combination with HealthCor Catalio Acquisition Corp and Liminal Sciences, Will Begin Trading under the Ticker "HYPR" on the Nasdaq Global MarketDecember 22, 2021 | finance.yahoo.comHealthCor Catalio Acquisition Corp. Reminds Shareholders to Vote in Favor of the Business Combination with Hyperfine, Inc. and Liminal Sciences, Inc.December 15, 2021 | finance.yahoo.comHCAQ, BPTS, FWAA, and CCV Company DescriptionsBiophytis NASDAQ:BPTSBiophytis S.A., a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases. Its therapeutics focuses on targeting and activating key biological resilience pathways that could protect against and counteract the effects of the multiple biological and environmental stresses including inflammatory, oxidative, metabolic, and viral stresses that lead to age-related diseases. The company's lead drug candidate is Sarconeos (BIO101), an orally administered small molecule in development for the treatment of neuromuscular diseases, including sarcopenia and Duchenne muscular dystrophy (DMD), as well as in Phase 2/3 clinical study for the treatment of severe respiratory failure in patients suffering from COVID-19. It also develops Macuneos (BIO201), an orally administered small molecule for the treatment of retinal diseases, including dry age-related macular degeneration (AMD) and Stargardt disease. Biophytis SA has a collaboration agreement with AFM-Telethon for the development of its Sarconeos (BIO101) for the treatment of DMD. The company was incorporated in 2006 and is headquartered in Paris, France.Churchill Capital Corp V NYSE:CCVChurchill Capital Corp V does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as One Judith Acquisition Corp. Churchill Capital Corp V was incorporated in 2020 and is based in New York, New York.Fifth Wall Acquisition Corp. I NASDAQ:FWAAFifth Wall Acquisition Corp. I focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses or entities. The company was founded in 2020 and is based in Los Angeles, California.HealthCor Catalio Acquisition NASDAQ:HCAQHealthCor Catalio Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Tesla’s Earnings Review: Does the Juice Justify the Squeeze? Capital One Just Flashed a Buy Signal—New Highs Could Be Next Why Intuitive Surgical Is a No-Brainer for Long-Term Investors Is Oracle’s AI Rally Over? Wall Street Thinks ORCL Could Hit $400 GM Posts Largest Gain Since the Pandemic: Shares Still Look Cheap 3 Pharmaceutical Growth Stocks to Buy and Hold for 10 Years Why Micron Stock Could Soar 35% on AI Memory Demand WesBanco Insiders Signal Confidence With Coordinated Buys Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
